Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. Sartorius Stedim Biotech
  6. Summary
    DIM   FR0013154002

SARTORIUS STEDIM BIOTECH

(DIM)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Real-time Quote. Real-time Euronext Paris
01/17/2022 01/18/2022 01/19/2022 01/20/2022 01/21/2022 Date
376.5(c) 364.1(c) 374.3(c) 383.5(c) 377(c) Last
62 887 66 736 69 309 57 759 56 706 Volume
+2.59% -3.29% +2.80% +2.46% -1.69% Change
More quotes
Estimated financial data (e)
Sales 2021 2 874 M 3 259 M 3 259 M
Net income 2021 595 M 675 M 675 M
Net Debt 2021 538 M 610 M 610 M
P/E ratio 2021 59,1x
Yield 2021 0,37%
Sales 2022 3 334 M 3 781 M 3 781 M
Net income 2022 696 M 789 M 789 M
Net Debt 2022 284 M 322 M 322 M
P/E ratio 2022 50,6x
Yield 2022 0,46%
Capitalization 34 752 M 39 415 M 39 409 M
EV / Sales 2021 12,3x
EV / Sales 2022 10,5x
Nbr of Employees 9 619
Free-Float -
More Financials
Company
Sartorius Stedim Biotech SA is a France-based international provider of laboratory and process technologies and equipment. The Company covers the segments of biotechnology and mechatronics. Sartorius provides services which help customers to implement complex and quality-critical processes in biopharmaceutical production and laboratory environments in a time- and cost-efficient way. The Company’s customers are... 
More about the company
Ratings of Sartorius Stedim Biotech
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B
More Ratings
All news about SARTORIUS STEDIM BIOTECH
01/05SARTORIUS STEDIM BIOTECH : Half-year H2 2021 liquidity contract statement for Sartorius St..
PU
01/05SARTORIUS STEDIM BIOTECH SA : Half-year liquidity contract statement for Sartorius Stedim ..
EQ
2021SARTORIUS STEDIM BIOTECH : Monthly statement on outstanding equity shares and voting right..
CO
2021Sartorius Acquires Majority Stake in ALS Automated Lab Solutions
DJ
2021SARTORIUS STEDIM BIOTECH : strengthens its bioanalytics portfolio by acquiring a...
PU
2021Sartorius To Buy 63% Interest In Germany's ALS Automated Lab Solutions
MT
2021Sartorius to Pay $11.3 Million COVID-19 Bonus to Employees
MT
2021SARTORIUS STEDIM BIOTECH : Monthly statement on outstanding equity shares and voting right..
CO
2021Jiangsu Nhwa Pharma Signs Nearly $18 Million Deal to License Lundbeck's Schizophrenia D..
MT
2021Sartorius to Invest EUR100 Million in France by 2025, Create Up to 400 Jobs
DJ
2021SARTORIUS STEDIM BIOTECH : grows operations in France and is investing 100 million...
PU
2021Sartorius to Invest Around EUR270 Million in South Korea Expansion
DJ
2021SARTORIUS STEDIM BIOTECH : significantly expands activities in South Korea
PU
2021CHA BIOTECH : Unit Signs Contract with Sartorius for Viral Vectors Process Technology
MT
2021GLOBAL MARKETS LIVE : Kering, Netflix, Roche, United Airlines, Xiaomi...
More news
News in other languages on SARTORIUS STEDIM BIOTECH
01/2112 TERMINE, die in der Woche wichtig werden
01/21WOCHENAUSBLICK : Dax vor schwierigen Tagen - Tech-Konzerne und Fed im Fokus
01/20AKTIEN FRANKFURT SCHLUSS : Erholung im Technologiesektor gibt Auftrieb
01/20XETRA-SCHLUSS/DAX zeigt Stärke und Puma Ausdauer
01/20AKTIEN FRANKFURT : Dax stabilisiert sich weiter
More news
Analyst Recommendations on SARTORIUS STEDIM BIOTECH
More recommendations
Stock Trading Strategies
SARTORIUS STEDIM BIOTECH - 2021
Technically solid
BUY
More Stock Trading Analysis
Chart SARTORIUS STEDIM BIOTECH
Duration : Period :
Sartorius Stedim Biotech Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SARTORIUS STEDIM BIOTECH
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 10
Last Close Price 377,00 €
Average target price 471,11 €
Spread / Average Target 25,0%
EPS Revisions
Managers and Directors
Joachim Kreuzburg Chairman & Chief Executive Officer
Oscar-Werner Reif Executive VP-Research & Development
Henri Riey Independent Non-Executive Director
Anne-Marie Graffin Independent Non-Executive Director
Susan Dexter Independent Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
SARTORIUS STEDIM BIOTECH-21.85%39 415
ABBOTT LABORATORIES-10.59%215 794
MEDTRONIC PLC2.57%141 985
BECTON, DICKINSON AND COMPANY5.23%75 431
HOYA CORPORATION-11.34%49 186
BAXTER INTERNATIONAL INC.0.51%43 200